Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

Tardive Dyskinesia Excellence Forum

Tardive Dyskinesia
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

What purpose does patient questions serve when screening for TD?
Quiz
What purpose does patient questions serve when screening for TD?
06/22/2023
Do you remember Nurse Hoberg's insights?
Do you remember Nurse Hoberg's insights?
Do you remember Nurse Hoberg's...
06/22/2023
Psych Congress Network
amber hoberg, np
Videos
'Activation Maneuvers' Can Help Identify Mild to Moderate TD
06/08/2023
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses how providers can reassess treatment plans should TD develop and what practices can be incorporated to identify the disorder.
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses how providers can reassess treatment plans should TD develop and what practices can be incorporated to identify the disorder.
Amber Hoberg, MSN, APRN,...
06/08/2023
Psych Congress Network
amber hoberg, np
Expert Insights Quiz
What screeners should be used to diagnose tardive dyskinesia?
05/26/2023
True or False: According to Nurse Amber Hoberg, the AIMS is the only scale that should be used when screening a patient for tardive dyskinesia (TD).
True or False: According to Nurse Amber Hoberg, the AIMS is the only scale that should be used when screening a patient for tardive dyskinesia (TD).
True or False: According to...
05/26/2023
Psych Congress Network
amber hoberg, np
Videos
Patient-Centered Tools to Implement When Screening for Tardive Dyskinesia
05/11/2023
Tardive Dyskinesia Section Editor, Amber Hoberg, MSN, APRN, PMHNP-BC, discusses why tardive dyskinesia (TD) continues to be underdiagnosed and what screening tools should be used to diagnose the disorder with patient needs in mind.
Tardive Dyskinesia Section Editor, Amber Hoberg, MSN, APRN, PMHNP-BC, discusses why tardive dyskinesia (TD) continues to be underdiagnosed and what screening tools should be used to diagnose the disorder with patient needs in mind.
Tardive Dyskinesia Section...
05/11/2023
Psych Congress Network
desiree matthews
Videos
Finding Treatment Options for Tardive Dyskinesia
04/10/2023
Desiree Matthews, PHMNP-BC, shares her personal clinical journey with treating tardive dyskinesia (TD) in her patients as a clinician who does not prescribe typical agents to treat mental health conditions. 
Desiree Matthews, PHMNP-BC, shares her personal clinical journey with treating tardive dyskinesia (TD) in her patients as a clinician who does not prescribe typical agents to treat mental health conditions. 
Desiree Matthews, PHMNP-BC,...
04/10/2023
Psych Congress Network
dr kaye and bradley
Q&As
Preventing, Recognizing, and Treating Tardive Dyskinesia in Patients Taking Antipsychotics
03/01/2023
What does prevention-based TD treatment look like with 2 FDA-approved medications as an option? What should clinicians do should TD develop in their patient? These answers and more.
What does prevention-based TD treatment look like with 2 FDA-approved medications as an option? What should clinicians do should TD develop in their patient? These answers and more.
What does prevention-based TD...
03/01/2023
Psych Congress Network
quiz
Expert Insights Quiz
How does tardive dyskinesia impact medication adherence?
02/14/2023
True or false: Patients with Tardive Dyskinesia (TD) have high rates of antipsychotic medication non-adherence partly due to their TD symptoms.
True or false: Patients with Tardive Dyskinesia (TD) have high rates of antipsychotic medication non-adherence partly due to their TD symptoms.
True or false: Patients with...
02/14/2023
Psych Congress Network
desiree mathews at psych congress elevate
Videos
Addressing Antipsychotic Non-Adherence in Tardive Dyskinesia
02/06/2023
Desiree Matthews, PHMNP-BC discusses the high rates of antipsychotic non-adherence and how tolerability plays into treatment success.
Desiree Matthews, PHMNP-BC discusses the high rates of antipsychotic non-adherence and how tolerability plays into treatment success.
Desiree Matthews, PHMNP-BC...
02/06/2023
Psych Congress Network
Chepke
Your Questions Answered
Treating Tardive Dyskinesia With Patient's Individual Needs and Age in Mind
01/05/2023
Craig Chepke, MD, FAPA, shares why it is important to try both FDA approved VMAT 2 inhibitors when treating TD and over 60 years old.
Craig Chepke, MD, FAPA, shares why it is important to try both FDA approved VMAT 2 inhibitors when treating TD and over 60 years old.
Craig Chepke, MD, FAPA, shares...
01/05/2023
Psych Congress Network
Craig Chepke, MD, FAPA
Your Questions Answered
Is high blink rate a symptom of Tardive Dyskinesia? With Dr Craig Chepke
12/07/2022
Dr Chepke answers questions surrounding TD: high blink rate and AIMS exam over telehealth.
Dr Chepke answers questions surrounding TD: high blink rate and AIMS exam over telehealth.
Dr Chepke answers questions...
12/07/2022
Psych Congress Network

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement